DENT 3005: Introduction to Pharmacology1
Hormonal drugs
Dr Thuy Linh Truong thuy.truong@uwa.edu.au
Acknowledgement of country2
The University of Western Australia acknowledges that its campus is situated on Noongar land, and that Noongar people remain the spiritual and cultural custodians of their land, and continue to practise their values, languages, beliefs and knowledge.
Artist: Dr Richard Barry Walley OAM
Learning Outcomes3
Learning objectives
- Identify major endocrine gland the the hormones they produce
- Basic understanding of steroid hormones
- Broad understanding of the pituitary gland and the various hormones it produces and their function
- Broad understanding of estrogen, progestogens and androgen drugs and their implications in the dental setting
- Applied knowledge to clinical scenarios
World Health Organization4
Gender and Hormonal therapy
- Gender refers to the characteristics of women, men, girls and boys that are socially constructed.
- This includes norms, behaviours and roles associated with being a woman, man, girl or boy, as well as relationships with each other.
- As a social construct, gender varies from society to society and can change over time.
- As a healthcare professional, we need to be treating patients with justice regardless of gender.
- Gender is not the same as Sex.
If unsure → Ask
Testosterone and Steroid Hormone Action5
Testosterone in males
- Made by Leydig cells (testes)
- Role: reproductive development, secondary sex traits, muscle/bone maintenance
Testosterone in females
- Made by ovaries & adrenal glands
- Role: libido, muscle strength, bone density, estrogen precursor
Diagram showing testosterone sources and its mechanism of action:
Left Side (Testosterone Sources):
- Men:
- Adrenal glands
- Testicles
- Produces Testosterone (chemical structure shown)
- Women:
- Adrenal glands
- Ovaries
- Produces Testosterone (chemical structure shown)
Right Side (Mechanism of Action - Steroid Hormone Action):
- Steroid molecules (small blue hexagons/dots) diffuse across the Cell membrane.
- Inside the cell cytoplasm, the steroid molecule binds to an intracellular receptor (red and blue complex with a cavity).
- This binding causes a Conformational (allosteric) change in receptor structure (indicated by the receptor changing shape and color, shown by a green curve representing the conformational change).
- The activated Steroid-Receptor complex then enters the Nuclear membrane.
- Inside the nucleus, the complex acts as a Transcription factor, binding to the Steroid response element (SRE) on the DNA.
- RNA polymerase binds to the promoter region (indicated by ATG and TAA).
- Transcription occurs, leading to the formation of pre-mRNA.
- The pre-mRNA undergoes Processing (splicing out introns, represented by A, B, C, D, E, F, G segments).
- The mature mRNA is then Exported out of the nucleus.
- In the cytoplasm, the mRNA undergoes Translation (AUG and UAA codons indicated), forming a New protein (polypeptide chain).
- This Altered cell function is the final result of the steroid hormone action.
Legend/Key:
- Steroid molecules
- Conformational (allosteric) change in receptor structure
Steroid hormone mechanism6
- Lipid-soluble → crosses cell membrane
- Binds intracellular receptors (cytoplasm/nucleus)
- Activates receptor → hormone-receptor binds DNA (HREs)
- Regulates gene transcription → alters protein synthesis
Examples
- Cortisol: stress, inflammation
- Estrogen: reproduction, bones
- Testosterone: muscle, bones, sex traits
An image illustrating the production of Testosterone in Men (Adrenal glands and Testicles) and Women (Adrenal glands and Ovaries), and a diagram of the steroid hormone mechanism of action within a cell, showing the hormone crossing the cell membrane, binding to an intracellular receptor, regulating gene transcription in the nucleus, and altering protein synthesis in the cytoplasm.
The pituitary Gland7
- A tiny gland at the base of the brain: small but mighty!!!
- A major endocrine gland!
- Produces a wide variety or hormones that travels to regulate other glands & organs in the body
- Anterior lobe: GH, ACTH, TSH, FSH, LH
- Posterior lobe: ADH, oxytocin
Brain and hormones8
- Hypothalamus releases GnRH
- GnRH signals pituitary to release FSH and LH
FSH
- Stimulates egg growth
- Promotes estrogen production
- Prepares for ovulation
LH
- LH surge triggers ovulation
Hormonal contraceptives
- Combined pill
- Estrogen inhibits FSH and LH
- Progestogen inhibits LH and thickens cervical mucus
- Progestin-only pill
- Thickens cervical mucus
- Alters endometrium to prevent implantation
No pregnancy
- Corpus luteum degenerates
- Estrogen and progesterone levels drop
- Endometrial lining sheds, leading to menstruation
flowchart TD A[Hypothalamus] -->|GnRH| B(GnRH) B -->|Activates(+)| C[Anterior pituitary] C -->|FSH| D{FSH} C -->|LH| E{LH} D -->|Activates(+)| F[Ovary] E -->|Activates(+)| F F -->|Maturation| G{Oestrogens} F -->|Ovulation| G F -->|Corpus Luteum (CL)| H{Progesterone} G -->|Inhibits(-)| C H -->|Inhibits(-)| C G -->|Inhibits(-)| A H -->|Inhibits(-)| A subgraph Hormonal contraceptives J[Combined pill] K[Progestin-only pill] J --> L[Estrogen inhibits FSH and LH] J --> M[Progestogen inhibits LH and thickens cervical mucus] K --> N[Thickens cervical mucus] K --> O[Alters endometrium to prevent implantation] end subgraph No pregnancy P[Corpus luteum degenerates] P --> Q[Estrogen and progesterone levels drop] Q --> R[Endometrial lining sheds, leading to menstruation] end
Estrogen9
- Replacement therapy
- Menopause – Flushing, vaginal dryness, Preserve bone mass
- Tablets, patches are most commonly used
- Contraception
- Combination: ethinylestradiol, oestradiol
- Antiestrogen
- Oestrogen-sensitive breast cancer (Tamoxifen)
- Induce ovulation (Clomiphene) in treating infertility
| Generic name | Brand Name |
|---|---|
| COCs | Yaz, Femme, |
| Ethinyloestradiol | Zoley, Brenda, |
| Oestradiol | Madeline… |
| Mestranol | many more |
Progestogen10
- Contraception e.g. Norethisterone, Levonorgestrel
- Combined with Oestrogen
- Progesterone only [Oral, Injection, Implant, Intrauterine] e.g. Medroxyprogesterone, Etonogesterol
- Endometriosis
- Antiprogestogens
- Medical termination of pregnancy (Mifepristone)
| Generic name | Brand Name |
|---|---|
| Drospirenone | |
| Levonorgestrel | |
| Nomegestrol | |
| Norethisterone | |
| Many more+++ | |
| Etonogestrel | Implanon NXT |
| Medroxyprogesterone | Provera |
Androgens11
- Aka anabolic steroids
- Bind & activate androgen receptors
- Hormone replacement
- Male hypogonadism
- Anti-androgens e.g. Flutamide, Cyproterone
- Indication: tx of prostatic cancer, COCs
- 5α-Reductase inhibitors e.g. finasteride
- Indication: benign prostatic hyperplasia
| Generic name | Brand Name |
|---|---|
| Testosterone | Testogel |
| COCs cyproterone | Brenda, Carolyn, Diane, Estelle |
| Finasteride | Finpro |
Hormonal drugs12
Dental implications
- Hormonal based medications can exacerbate gingival overgrowth
- ADR: dry mouth, taste disturbances
- Oral contraceptive
- Potential risk factor for dry socket after dental extraction
Case 1: the menopause mambo13
- Scenario
- Mrs. Canine, a 54-year-old woman, presents for her routine dental exam.
- Medical history: started HRT for menopause
- Medication history: estrogen patches
- Clinical findings: gingival inflammation, despite excellent plaque control
- Patient also reports recent dry mouth
- Discussion Points
- How might hormonal replacement therapy influence salivary flow and increase xerostomia risk in postmenopausal patients?
- Why is it important to recognize inflammation in patients with good plaque control, especially those on HRT?
- What preventative or supportive strategies can we offer patients experiencing hormone-related oral dryness?
Case 2: “my gum has a tumor!”14
- Scenario
- Mrs Lip, a 32-year-old woman, presents for her routine dental exam
- Medical history: pregnant in her trimester, borderline gestational diabetes
- Medication history: Elevit
- Presenting concern: “I have a lump around my canine”
- Discussion Points
- How does pregnancy affect gingival health?
- Why is periodontal monitoring critical in diabetic patients?
- What role does patient education play in managing oral health during pregnancy?
References15
- Ritter JM, Flower RJ, Henderson G, Loke YK, MacEwan D, Robinson E, editors. Rang & Dale’s pharmacology. 10th ed. Edinburgh: Elsevier; 2023
- Shigehara K, Izumi K, Kadono Y, Mizokami A. Testosterone and bone health in men: a narrative review. J Clin Med. 2021;10(3):530. doi:10.3390/jcm10030530
- Australian Medicines Handbook Online [Internet]. Adelaide (AU): Australian Medicines Handbook Pty Ltd;2000. Obstetrics and Gynaecological; [updated 2025; cited 2025]. Available from: UWA Onesearch
- Pharmaceutical Society of Australia. Australian Pharmaceutical Formulary and Handbook: A Guide to Best Practice. 25th ed. Canberra: Pharmaceutical Society of Australia; 2021
- Ali K. Clinical dental pharmacology. 1st ed. Oxford: Wiley-Blackwell; 2023
- Bullock S, Manias E. Fundamentals of pharmacology. 8th ed. Frenchs Forest, NSW: Pearson Australia; 2017
- MIMS Australia. eMIMSelite: Consumer medicine information, specific clinical monograph [Internet]. Sydney: MIMS Australia; [updated 2025; cited 2025 Apr 17]. Available from: UWA Onesearch
Footnotes
-
Original PDF page 1: L11 HORMONAL DRUGS 2025, p.1 ↩
-
Original PDF page 2: L11 HORMONAL DRUGS 2025, p.2 ↩
-
Original PDF page 3: L11 HORMONAL DRUGS 2025, p.3 ↩
-
Original PDF page 4: L11 HORMONAL DRUGS 2025, p.4 ↩
-
Original PDF page 5: L11 HORMONAL DRUGS 2025, p.5 ↩
-
Original PDF page 6: L11 HORMONAL DRUGS 2025, p.6 ↩
-
Original PDF page 7: L11 HORMONAL DRUGS 2025, p.7 ↩
-
Original PDF page 8: L11 HORMONAL DRUGS 2025, p.8 ↩
-
Original PDF page 9: L11 HORMONAL DRUGS 2025, p.9 ↩
-
Original PDF page 10: L11 HORMONAL DRUGS 2025, p.10 ↩
-
Original PDF page 11: L11 HORMONAL DRUGS 2025, p.11 ↩
-
Original PDF page 12: L11 HORMONAL DRUGS 2025, p.12 ↩
-
Original PDF page 13: L11 HORMONAL DRUGS 2025, p.13 ↩
-
Original PDF page 14: L11 HORMONAL DRUGS 2025, p.14 ↩
-
Original PDF page 15: L11 HORMONAL DRUGS 2025, p.15 ↩